Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAPID VITILIGO: Apremilast and Phototherapy in Diffuse Vitiligo
NCT03036995Phase 2Completed
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Start
- Mar 2017
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of apremilast in Vitiligo, sponsored by Centre Hospitalier Universitaire de Nice. Started Mar 2017; status: completed.
02
Drugs
apremilast
03
Conditions
Vitiligo
Beyond the preview
Go deeper on NCT03036995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03036995.